Climara

What it is used for

OTHER CONDITIONS: Do not remove from primary pack except for immediate use. For short term treatment of signs and symptoms of oestrogen deficiency due to the menopause, whether natural or surgically induced. Oestradiol prevents the accelerated loss of bone density due to oestrogen deficiency and may be used for the prevention of post-menopausal bone mineral density loss. In women with an intact uterus, oestrogen should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals.,For short term treatment of signs and symptoms of oestrogen deficiency due to the menopause, whether natural or surgically induced. For the prevention of post menopausal bone mineral density loss. When prescribed solely for the prevention of post menopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of osteoporosis and future fracture and who, are intolerant of, or contraindicated for non-oestrogen products approved for prevention of osteoporosis. Lifestyle modifications and the risk benefit profile of CLIMARA should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing (see precautions and dosage and administration sections). In women with an intact uterus, oestrogen should always be opposed by a progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals.